| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 43.582 | 47.851 | 57.713 | 62.602 | 25.932 | 60.064 | 53.380 | 58.411 | 59.374 |
| Total Income - EUR | - | 43.582 | 47.851 | 57.713 | 62.602 | 25.932 | 60.064 | 53.380 | 58.411 | 59.374 |
| Total Expenses - EUR | - | 11.137 | 20.207 | 21.766 | 27.207 | 4.138 | 17.363 | 15.342 | 16.102 | 15.694 |
| Gross Profit/Loss - EUR | - | 32.445 | 27.644 | 35.948 | 35.395 | 21.794 | 42.701 | 38.038 | 42.310 | 43.679 |
| Net Profit/Loss - EUR | - | 32.009 | 27.166 | 35.370 | 34.769 | 21.502 | 42.100 | 37.504 | 41.725 | 41.898 |
| Employees | - | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Persu Monica S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 8 | 1.379 | 1.286 | 5.316 | 3.554 | 4.822 | 1.872 | 56 | 0 |
| Current Assets | - | 32.523 | 41.433 | 42.024 | 29.532 | 30.446 | 57.574 | 47.614 | 44.195 | 47.823 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 4.496 | 3.165 | 5.952 | 0 | 7.862 | 40.616 | 30.961 | 22.790 | 39.414 |
| Cash | - | 28.027 | 38.268 | 36.072 | 29.532 | 22.583 | 16.958 | 16.653 | 21.405 | 8.409 |
| Shareholders Funds | - | 32.054 | 27.210 | 35.413 | 34.811 | 21.543 | 42.149 | 37.552 | 41.774 | 41.946 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 477 | 15.603 | 7.896 | 36 | 12.457 | 20.247 | 11.933 | 2.477 | 5.877 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dr. Persu Monica S.r.l.